CLL therapy - current status and issues
3-year update on the ELOQUENT-2 clinical trial of elotuzumab in multiple myeloma
ADCT-402 - a drug to watch
Latest research in Hodgkin lymphoma
Why do charities need to keep funding research into leukemia and blood cancer in general?